6.
Chuansumrit A, Sirachainan N, Kitpoka P, Kadegasem P, Songdej D, Sasanakul W
. The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia. Hemoglobin. 2019; 43(4-5):264-272.
DOI: 10.1080/03630269.2019.1692863.
View
7.
Zhang J, Li P, Yang Y, Yan Y, Zeng X, Li D
. Molecular epidemiology, pathogenicity, and structural analysis of haemoglobin variants in the Yunnan province population of Southwestern China. Sci Rep. 2019; 9(1):8264.
PMC: 6547717.
DOI: 10.1038/s41598-019-44793-0.
View
8.
Tan M, Bai Y, Zhang X, Sun J, Huang C, Tian R
. Early genetic screening uncovered a high prevalence of thalassemia among 18 309 neonates in Guizhou, China. Clin Genet. 2021; 99(5):704-712.
DOI: 10.1111/cge.13923.
View
9.
Pornprasert S, Panyasai S, Kongthai K
. Comparison of capillary electrophoregram among heterozygous Hb Hope, Hb Hope/α-thalassemia-1 SEA type deletion and Hb Hope/β(0)-thalassemia. Clin Chem Lab Med. 2012; 50(9):1625-9.
DOI: 10.1515/cclm-2012-0016.
View
10.
Xu A, Chen W, Xie W, Wang Y, Ji L
. Hemoglobin variants in southern China: results obtained during the measurement of glycated hemoglobin in a large population. Clin Chem Lab Med. 2020; 59(1):227-232.
DOI: 10.1515/cclm-2020-0767.
View
11.
Harteveld C, Achour A, Arkesteijn S, Ter Huurne J, Verschuren M, Bhagwandien-Bisoen S
. The hemoglobinopathies, molecular disease mechanisms and diagnostics. Int J Lab Hematol. 2022; 44 Suppl 1:28-36.
PMC: 9542123.
DOI: 10.1111/ijlh.13885.
View
12.
Lage J, Monteiro B, Costa A, Mendes I, Ferreira T, Loureiro H
. Acute Complications of Sickle Cell Disease in Children Under 5 Years at a Level II Hospital. Glob Pediatr Health. 2022; 9:2333794X221141356.
PMC: 9742710.
DOI: 10.1177/2333794X221141356.
View
13.
Xu G, Wang C, Wang J, Lin M, Chang Z, Liang J
. Prevalence and molecular characterization of common thalassemia among people of reproductive age in the border area of Guangxi-Yunnan-Guizhou province in Southwestern China. Hematology. 2022; 27(1):672-683.
DOI: 10.1080/16078454.2022.2080427.
View
14.
Brennan S, Tauro G, Melrose W
. Haemoglobin Port Phillip alpha91 (FG3) Leu replaced by Pro, a new unstable haemoglobin. FEBS Lett. 1977; 81(1):115-7.
DOI: 10.1016/0014-5793(77)80940-x.
View
15.
Xi H, Liu Q, Xie D, Zhou X, Tang W, Tang D
. Epidemiological Survey of Hemoglobinopathies Based on Next-Generation Sequencing Platform in Hunan Province, China. Biomed Environ Sci. 2023; 36(2):127-134.
DOI: 10.3967/bes2023.016.
View
16.
Weatherall D, Clegg J
. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001; 79(8):704-12.
PMC: 2566499.
View
17.
Baruah A, Baruah M
. Phenotypic Diversity and Clinico-Hematological Profile of Hb E-Beta Thalassemic Children. Indian J Hematol Blood Transfus. 2020; 36(1):117-122.
PMC: 7042447.
DOI: 10.1007/s12288-019-01150-5.
View
18.
Chen Y, Wu P, Wang H, Wu J, Xie D, Wang L
. A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [: c.206T > C β 68(E12) Leu-Pro]: A First Report in the Chinese Population. Hemoglobin. 2023; 47(3):130-134.
DOI: 10.1080/03630269.2023.2231851.
View
19.
Modell B, Darlison M
. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008; 86(6):480-7.
PMC: 2647473.
DOI: 10.2471/blt.06.036673.
View
20.
Xiong F, Sun M, Zhang X, Cai R, Zhou Y, Lou J
. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010; 78(2):139-48.
DOI: 10.1111/j.1399-0004.2010.01430.x.
View